We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Key considerations in navigating ticagrelor's reported effect on heparin-induced thrombocytopenia functional assays in a landscape of limited data.
- Authors
Salman, Genene; Johannesmeyer, Herman J; Breen, Martin J
- Abstract
Purpose This article discusses key considerations regarding ticagrelor's reported effect on heparin-induced thrombocytopenia functional assays, such as literature gaps and possible management strategies. Summary Limited data indicate that ticagrelor may induce false-negative results in functional assays used in the diagnosis of heparin-induced thrombocytopenia. False-negative functional assays for heparin-induced thrombocytopenia could have catastrophic consequences. The manufacturer labeling of ticagrelor now includes a warning for this potential drug-laboratory interaction. This article suggests areas that would benefit from further research and strategies in navigating this possible interaction. Conclusion Clinicians should exercise caution when evaluating functional assays for heparin-induced thrombocytopenia in patients receiving ticagrelor. This article offers suggestions for future areas of research and potential management strategies.
- Subjects
HEPARIN; STRATEGIC planning; DIAGNOSTIC errors; THROMBOCYTOPENIA; DRUG interactions; PLATELET aggregation inhibitors; BIOLOGICAL assay; DRUG labeling
- Publication
American Journal of Health-System Pharmacy, 2024, Vol 81, Issue 12, p488
- ISSN
1079-2082
- Publication type
Article
- DOI
10.1093/ajhp/zxae040